Overactive bladder syndrome (2023)

Table 1. Definitions of overactive bladder syndrome
Detrusor overactivityA urodynamic observation characterised by involuntary spontaneous or provoked detrusor contractions during the filling phase2,12
Nocturnal polyuriaAn excess (>20–30%) proportion of urine excretion at night2
Polyuria>40 mL urine/kg body weight during 24 hours
Postvoid residual volumeThe volume of fluid remaining in the bladder at the completion of micturition2
UrgencyA sudden, compelling desire to void that is difficult to defer2,6
Urinary frequency>8 micturitions/24 hours
Urgency urinary incontinenceInvoluntary loss of urine associated with urgency2

Clinical significance

In Australia, prevalence of urinary incontinence has been reported at 42% and the incidence of urge-only incontinence at 16%.7 Worldwide prevalence of OBS is 12.8% for women and 10.8% for men.8 The prevalence of all incontinence increases with age.7,8 Appropriate management can decrease both morbidity and costs.9

When compared with demographically matched controls, patients with OBS have:10,11

  • significantly less work productivity
  • less sexual satisfaction and more erectile dysfunction
  • higher rates of depressive symptoms
  • significantly poorer mental health
  • poorer quality of sleep.

Postmenopausal women with urge incontinence have a significantly higher risk of falling and sustaining a fracture than women without urge incontinence.4

Causes

The symptoms of OBS have many potential causes and contributing factors. Normal storage of urine is dependent on spinal reflex mechanisms that activate sympathetic and somatic pathways to the urethral outlet and tonic inhibitory systems in the brain that suppress the parasympathetic excitatory outflow to the urinary bladder.4

The normal bladder fills like a compliant balloon, with pressure lower than urethral resistance. Initiation of urination decreases urethral resistance and phasic contraction of the detrusor muscle empties the bladder.4

Overactive bladder symptoms are usually associated with involuntary contractions of the detrusor muscle, which can result in urge incontinence, depending on the response of the sphincter.4 The most common cause of OBS is detrusor overactivity (DO);2,12 64% of all patients with OBS have DO on cystometry, and 69% of men and 44% of women with urgency have DO.1 Detrusor overactivity is thought to result not only from efferent (motor) hyper function/dysfunction but also most likely by afferent (sensory) noise. Patients with OBS seem to respond to antimuscarinic treatment irrespective of the presence of DO.13

Risk factors for OBS include vaginal birth delivery,14 with 40% of parous women experiencing urge urinary incontinence, older age, obesity and chronic constipation.15 Childhood urinary symptoms in women have been found to be independently associated with adult lower urinary tract symptoms, specifically urgency, frequency and nocturia.16

Diagnosis

Overactive bladder syndrome is a diagnosis of exclusion. A focused history, including past history of urogenital disorders, in combination with physical examination of the genitourinary system and relevant pelvic examinations should be performed as there are multiple conditions that can cause or contribute to symptoms of overactive bladder.4,17 Initial and secondary investigations are listed in Table 2.

(Video) OverActive Bladder Syndrome

Table 2. Investigations for overactive bladder syndrome
Initial investigations42
  • Urinalysis to exclude infection, haematuria and glycosuria
  • Urinary tract ultrasound and measurement of postresidual volume
  • Frequency/volume chart for at least 3 days
  • Bladder diary for a minimum of 3 days
Secondary investigations19
  • Urine cytology
  • Urodynamic testing
  • Cystoscopy
  • Imaging of upper urinary tract or spine

Postvoid residual volume (PVR)2 is best measured with ultrasound (bladder scan or formal ultrasound), with the upper limit of normal being 30 mL.2 An initially raised PVR requires confirmation before being considered significant2 as it can be subject to error.

Increased PVR may contribute to urinary frequency and nocturia, and commencing anticholinergic medications in a patient with increased PVR may worsen bladder function and potentiate urinary retention.18

A frequency/volume chart can exclude 24-hour polyuria due to diabetes insipidus, and nocturnal polyuria. It is an invaluable tool in OBS as it gives a better picture of the pattern of voiding than can be obtained from the symptoms alone.1 Three-day voiding diaries are as reliable as seven-day diaries.2 Information obtained should include number of voids in daytime, night time, 24 hour period, volume of urine over 24 hours, maximum voided volume, average voided volume, median maximum voided volume, and nocturnal urine volume. An assessment of severity of incontinence in terms of leakage episodes and pad usage2 can also be obtained.

Secondary investigations should be considered in patients with neurological disease, refractory OBS, or those in whom initial investigations raise the suspicion of an underlying problem that may require further evaluation or treatment19 (Table 3).

Table 3. Indications for urodynamic assessment17
Suspicion of occult diagnosis that may alter management
  • Bladder outlet obstruction
  • Detrusor hyperactivity with impaired contractility
  • Impaired bladder compliance
  • Dysfunctional voiding
  • Mixed incontinence
Risk of upper urinary tract deterioration
  • History of pelvic irradiation
  • Radical pelvic surgery (abdomino-perineal resection, radical hysterectomy)
  • Spina bifida
  • Neurogenic voiding dysfunction (eg. multiple sclerosis, spinal cord injury)
Other
  • Failed or unsatisfactory response to empiric medical therapy
  • Uncertain diagnosis
  • Unaware incontinence
  • Prior lower urinary tract surgery (eg. transurethral resection of prostate, anti-incontinence surgery)
  • Irreversible, potentially morbid intervention planned (ie. augmentation cystoplasty)

Urodynamic testing aims to demonstrate incontinence objectively and differentiate between different types of incontinence, so that the most effective method of treatment can be selected. Urodynamic investigations should also be used to demonstrate the presence of specific abnormalities before undertaking complex reconstructive urological procedures.20

Urine cytology, performed on three voided specimens obtained on three separate days, has a variable sensitivity for the detection of urothelial carcinoma.21 Urine cytology is effective for screening for high grade lesions (sensitivity at least 90%, specificity 98–100%) and carcinoma in situ. However, it is unreliable for detection of well differentiated, low grade lesions.21

Cystoscopy is indicated in patients with sterile haematuria and risk factors for bladder cancer, and in patients with recurrent urinary tract infections. Carcinoma in situ and other intravesical abnormalities can be assessed via cystoscopy. The possibility of prostate cancer should also be considered in men and assessed based on prostate-specific antigen, digital rectal examination findings and relevant risk factors.4

Treatment

Principles of treatment are to reduce urinary incontinence by changing patient behaviour and teaching continence skills.22

(Video) Overactive Bladder, Causes, Signs and Symptoms, Diagnosis and Treatment.

Up to one-third of women with urge only incontinence can undergo spontaneous resolution at 2 years.8 As OBS is a symptom complex, 'no treatment' is an acceptable choice for some patients and caregivers.23

First line therapy

This can be initiated in the primary care setting. It includes a combination of lifestyle interventions (Table 4), bladder training and behavioural modification. Antimuscarinic medications can be added if these measures fail to control symptoms.1,8,20,23,24

Table 4. Lifestyle interventions1,22
  • Altering fluid intake – decreasing to reduce incontinence and frequency, increasing to improve urine concentration
  • Smoking cessation
  • Dietary modification to eliminate possible bladder irritants (eg. reducing caffeine, alcohol and carbonated beverages). Caffeine is a mild diuretic and bladder irritant, and reducing intake can reduce both urge and stress incontinence
  • Weight reduction – central obesity places pressure on the bladder and may worsen urge incontinence25
  • Regulating bowel function to avoid constipation and straining during bowel movements

Behavioural treatments (Table 5) have been shown to be effective in older adults, reducing leakage by 50–80%.25 Behavioural training requires a highly motivated patient, and 20–30% will become dry. As behavioural treatments work gradually at first and rely on patient self management, it is important to follow patients regularly to see sustained behavioural changes.25

Table 5. Behavioural training as first line therapy
Goal
To improve control by teaching the patient to inhibit or interrupt detrusor contractions
Method
Pelvic floor muscle training with or without biofeedback. Mastering a voluntary contraction of the pelvic floor muscles will help to increase pressure within the urethra, inhibit detrusor contractions and control leakage of urine. Coaching and verbal feedback during vaginal examination can be as effective as biofeedback and electrical stimulation
  • An initial approach is by verbal explanation of the technique reinforced with written materials
  • An effective verbal explanation of proper contraction of the pelvic floor muscles is to tell the patient to tighten up the muscles that they use to hold in flatus.
  • These muscles can also be identified during a pelvic or digital rectal examination
  • An effective exercise prescription for older adults is to contract and relax their pelvic floor muscles for 2 seconds with 15 repetitions, three times per day. Patients should gradually increase the duration of squeeze/relaxations by about 1 second per week, until they achieve 10 second contractions and relaxations. At this point they can begin a maintenance prescription of 10 second contractions and relaxations with 10 repetitions once a day
  • Freeze and squeeze:
    • when a sense of urgency occurs, instead of rushing to the bathroom, stay still and repeatedly tighten the pelvic floor muscles without relaxing them until the urgency is gone. Walk to the bathroom at a normal pace
  • Repeat as needed
A maintenance program is essential to maintain strength and effectiveness
At least 3 months of supervised pelvic floor muscle training is required to see benefits
Continence management is often best guided by a continence trained professional (eg. nurse or physiotherapist)

Bladder training (Table 6) has been found to reduce daily urinary frequency and lower daily urinary incontinence compared to antimuscarinics alone.26

Table 6. Bladder training as first line therapy
Goal
To modify bladder function, reduce voiding frequency, increase bladder capacity and eliminate detrusor overactivity by using scheduled voiding rather than voiding in response to urgency
Method
  • The bladder diary is reviewed with the patient, and the longest comfortable interval between voiding is chosen. This interval is the starting point
  • Patients are instructed to empty the bladder on waking and then each time during the day when the interval is reached, and again before going to bed
  • If the patient feels the urge to void during the interval, patients are instructed to use urge suppression techniques, such as distraction or relaxation techniques or self affirming statements, to get them through to the scheduled voiding time
  • After 1–2 weeks, increase the time interval by 15 minutes, gradually increasing the interval between voids
  • Patients are also encouraged to sit down and take five slow deep breaths, concentrating on the breathing and not the bladder sensation
A minimum of 6 weeks training is required to see benefits

In women with cognitive impairment, prompted and timed voiding toileting programs are recommended.20

Medical noninvasive pharmacotherapy

In the primary care setting, patients presenting with typical overactive bladder symptoms can be treated empirically with an antimuscarinic agent and obtain clinical benefit without the need for invasive urodynamic procedures27 (Table 7).

Table 7. Medications available in Australia and proven to be effective for overactive bladder syndrome
DrugAdverse effectsNotes
Oxybutynin CR
5–15 mg/day
  • Dry mouth (68%)
  • Constipation (10%)
Dose response observed
Take 1 hour before food
Oxybutynin transdermal
3.9 mg twice weekly
  • Itchiness at site (14%)
  • Erythema at site (8%)
  • Dry mouth (7%)
  • Constipation (2.1%)
Transdermal delivery reduces the typical anticholinergic side effects of dry mouth and constipation
Tolterodine
2 mg twice per day
  • Dry mouth (23%)
  • Constipation (6%)
  • Dry eyes (4%)
Dose dependent effect with immediate release
Safe in men with bladder outlet obstruction
Expensive, not subsidised on the PBS3,2
Solifenacin
5–10 mg/day
  • Dry mouth (26%)
  • Constipation (12%)
  • Blurred vision (5%)
Steady state at 10 days due to long half-life
Darifenacin
7.5–15 mg/day
  • Dry mouth (35%)
  • Constipation (21%)
Steady state 4–5 hours
Dose response
Safety, efficacy and tolerability maintained with long term use
Not subsidised on the PBS
Vaginal oestrogen
(topical)
0.5 g cream nightly for 2
weeks then twice per week
  • Increased risk of breast cancer
  • Breast discomfort and pain
  • Local reactions
For postmenopausal women with vaginal atrophy
Contraindications: past history of breast cancer
Duloxetine
40 mg twice per day increasing to 60 mg
twice per day after 4 weeks
(for stress urinary incontinence)
  • Nausea (31%)
  • Dry mouth (16%)
  • Constipation (14%)
  • Insomnia (13%)
  • Fatigue (11%)
Efficacy for stress and mixed stress and urge incontinence
Can be used if anticholinergics are contraindicated for overactive bladder syndrome33
TGA indicated and PBS subsidised in Australia for major depressive disorder

Human bladder contraction is mediated mainly through stimulation of muscarinic receptors in the detrusor muscle by acetylcholine.12 Antimuscarinic agents act during the filling/storage phase of the micturition cycle by inhibiting afferent (sensory) input from the bladder, and directly inhibiting smooth muscle contractility.24 They are competitive antagonists, so with massive release of acetylcholine during micturition the drug effect is decreased and the muscle can contract.1,9

Antimuscarinic medications

Controlled release compounds are generally better tolerated than immediate release formulations, with similar efficacy. The majority of adverse events associated with antimuscarinic agents are due to inhibition of muscarinic receptors in organs other than the bladder7,28 (Table 8).

(Video) Living with Overactive Bladder (OAB) - Urology Care Foundation

Table 8. Antimuscarinic agents: when to think twice
Absolute contraindications
  • Closed angle glaucoma: anticholinergic medications substantially increase intraocular pressure which may threaten vision if not treated urgently41
  • High doses in ulcerative colitis can lead to paralytic ileus
  • A history of impaired gastric emptying or urinary retention10
Think twice
  • Elderly patients:
    • central adverse effects include sedation, confusion, delirium, cognitive impairment and psychotic symptoms42
    • signs of toxicity include urinary retention, agitation, hallucinations, seizures, cardiac arrhythmias and heart block42
    • close monitoring is required20
  • Patients who are on other medications metabolised via the hepatic cytochrome P450 (CYP450) family (eg. warfarin, omeprazole, erythromycin, fluoxetine)17
  • Men with bladder outlet obstruction:
    • 45–50% will have concurrent detrusor overactivity13
    • combination treatment with antimuscarinic agents and an alpha-blocker should be used with caution

If treatment with an antimuscarinic fails due to inadequate symptom control or unacceptable adverse effects, a second antimuscarinic (or duloxetine) can be trialled before considering second or third line therapies23 and a urological opinion. Dry mouth and constipation should be managed before abandoning effective antimuscarinic therapy.23

A Cochrane review29 evaluated anticholinergic medications versus nonpharmacologic treatment of OBS. Symptomatic improvements were more common in patients on anticholinergic drugs compared with bladder training (RR 0.73; 95% CI: 0.59–0.90), and the combination of anticholinergics with bladder training was associated with more improvement than bladder training alone (RR 0.55; 95% CI: 0.32–0.93). There is no clear evidence that one anticholinergic is better than another for treatment of OBS.29

Effects in the elderly

Cognitive dysfunction including memory loss and attention deficits are particular side effects in the elderly.7

Antimuscarinic medications differ in their propensity to cause central nervous system adverse events due to differences in lipophilicity and crossing of the blood-brain barrier. Oxybutinin may be the most likely to cross the blood-brain barrier.13

The use of anticholinergics should be carefully weighed against the potential cognitive risks in the older adult population,24 as long term exposure to anticholinergics may be associated with increased Alzheimer type pathology.30

The newer antimuscarinics for OBS – darifenacin, solifenacin and tolterodine – have a significantly reduced impact on cognitition compared with traditional agents. Similarly, oxybutinin transdermal gel does not seem to adversely affect cognition.31 Despite this, their use in the elderly may still contribute to cognitive impairment and appropriate monitoring is recommended.

Prescribing in the elderly

Oxybutinin can be started at 2.5 mg twice per day. The morning dose can be increased or a lunchtime dose added depending on severity and timing of symptoms. The maximum dose is 5 mg three times per day.32 High doses are often not well tolerated due to dry mouth, gritty eyes, exacerbation of gastrointestinal reflux and constipation.

Nonantimuscarinic medications

Duloxetine (a serotonin noradrenaline reuptake inhibitor) can be effective in both stress and mixed stress and urge incontinence.33 However, it is currently only Therapeutic Goods Administration (TGA) indicated and Pharmaceutical Benefits Scheme (PBS) subsidised in Australia for major depressive disorder. In clinical practice, most women discontinue duloxetine within 4 weeks due to adverse effects (Table 7).

(Video) Overactive Bladder

Failure of conservative and medical treatments warrants urology referral for further investigation with urodynamics, and more invasive therapies may be considered.1,4

Second line therapy

Intravesical botulinum toxin A (BoNT/A) prevents acetylcholine release at the neuromuscular junction, resulting in temporary chemodenervation and muscle relaxation for up to 6 months.34 The technique is to place multiple injections under cystoscopic guidance directly into the detrusor.35

Complete continence can be achieved in 40–80% of patients and bladder capacity improved by 56% for up to 6 months.36 Maximal benefit is between 2 and 6 weeks, maintained over 6 months. The injections can be repeated.35

Third line therapy

Sacral nerve stimulation involves an implantable electrode in the S3 foramen continuously stimulating the S3 nerve root, in order to stimulate the pudendal nerve. A temporary wire is initially placed under local anaesthetic for 5–7 days in both sides and a voiding diary is kept. An improvement of >50% in any parameters will enable a permanently implanted S3 lead on the side with the best clinical response. There is a potential benefit for up to 5 years in patients with OBS.37

Current indications for sacral nerve stimulation include refractory urge incontinence, refractory urgency and frequency, and idiopathic urinary retention.38

In augmentation cystoplasty, the bladder is enlarged by incorporating a variety of different patches into the native bladder, usually patches of bowel still attached to their mesentery (ileum, caecum or sigmoid colon).39 Indications for bladder augmentation include a small, contracted bladder and a dysfunctional bladder with poor compliance.40

Urinary diversion should be considered only when conservative treatments have failed, and if sacral nerve stimulation and augmentation cystoplasty are not appropriate or unacceptable to the patient.20

Key points

  • Overactive bladder syndrome is a symptomatic diagnosis consisting of urinary frequency, urgency and nocturia, with or without urge urinary incontinence.
  • There is a significant impact on quality of life, which can lead to depression and affect relationships. Patients are often too embarrassed to discuss symptoms with their GP.
  • Pathology such as urinary infection, diabetes, bladder stones, malignancy or an underlying neurological cause should be excluded.
    Initial treatment consists of a combination of lifestyle interventions, pelvic floor exercises, bladder training and antimuscarinic medications.
  • Care should be taken when prescribing antimuscarinic therapy in the elderly.

Conflict of interest: All authors completed the ICMJE Disclosure of Potential Conflicts of Interest form. Prem Rashid has been a visitor to the American Medical Systems (AMS) US manufacturing facility undertaking a cadaveric dissection clinic and observed operative procedures by high volume implant urologists affiliated with AMS during that time. He also has acted as a consultant for Coloplast, Astra Zeneca, Hospira and Abbott Pharmaceuticals. No commercial organisation initiated or contributed to the writing of the article.

(Video) What is Overactive Bladder Syndrome?

FAQs

How can I stop my overactive bladder? ›

Behavioral interventions are the first choice in helping manage an overactive bladder. They're often effective, and they carry no side effects.
...
Male pelvic floor muscles
  1. Pelvic floor muscle exercises. ...
  2. Biofeedback. ...
  3. Healthy weight. ...
  4. Scheduled toilet trips. ...
  5. Intermittent catheterization. ...
  6. Absorbent pads. ...
  7. Bladder training.
3 May 2022

Can you recover from overactive bladder? ›

More often than not, OAB is a chronic condition; it can get better, but it may not ever go away completely. To start with, doctors often recommend exercises such as Kegels to strengthen pelvic floor muscles and give you more control over your urine flow.

What is the main cause of overactive bladder? ›

Overactive bladder is a collection of symptoms that may affect how often you pee and your urgency. Causes include abdominal trauma, infection, nerve damage, medications and certain fluids. Treatment includes changing certain behaviors, medications and nerve stimulation.

How long does it take to fix overactive bladder? ›

To sum up, optimal duration of OAB pharmacotherapy and efficacy sustenance have not yet been determined. Based on our survey and literature review, it is proposed that OAB patients can be treated for their symptoms for 6–12 months and persistence to the drug therapy should be encouraged.

Is overactive bladder mental? ›

If you have overactive bladder (OAB), you know that it's a very real physical issue. But although the problem is physical, some time-tested methods for managing it are psychological. The mental strategies below may help control the urge to go.

What vitamin helps with bladder control? ›

Conclusions: High-dose intakes of vitamin C and calcium were positively associated with urinary storage or incontinence, whereas vitamin C and β-cryptoxanthin from foods and beverages were inversely associated with voiding symptoms.

Is overactive bladder lifelong? ›

Conversely, about 40% to 70% of urinary incontinence is due to overactive bladder. Overactive bladder is not life-threatening, but most people with the condition have problems for years.
...
Overactive bladder
DurationOften years
CausesUnknown
Risk factorsObesity, caffeine, constipation
10 more rows

How can I stop my overactive bladder naturally? ›

Natural remedies
  1. Foods to avoid. Foods and drinks, which are known to cause or worsen the symptoms of OAB include: ...
  2. Manage fluid intake. Drinking enough water is essential for health. ...
  3. Scheduled urination. ...
  4. Delayed urination. ...
  5. Double-void technique. ...
  6. Kegel contractions. ...
  7. Quitting smoking. ...
  8. Discussing medications with a doctor.
24 Apr 2017

How do you live with an overactive bladder? ›

Start by peeing every 2 hours, for example. If the urge comes before then, postpone peeing by doing kegels, Carmel says. If you can't make it to your scheduled time, do kegels and try postponing urination for 5 minutes. Gradually increase the time between pee breaks, which will help retrain your bladder muscles.

What is the best supplement for overactive bladder? ›

Magnesium. Magnesium is important for proper muscle and nerve function. Some doctors believe better magnesium levels can reduce bladder spasms, a common cause of incontinence.

What is the latest drug for overactive bladder? ›

Mirabegron is the first drug in a new class of oral therapy for overactive bladder (OAB).

Who is at risk for overactive bladder? ›

As a result, participants who are elderly, current smokers, and those hyperlipidemia, cardiovascular, and renal disease showed statistically significant higher risk group for OAB (Table 3).

Can you train an overactive bladder? ›

Bladder training, a program of urinating on schedule, enables you to gradually increase the amount of urine you can comfortably hold. Bladder training is a mainstay of treatment for urinary frequency and overactive bladder in both women and men, alone or in conjunction with medications or other techniques.

How often do you pee with overactive bladder? ›

Urinate frequently: OAB may also cause people to go to the bathroom many times during the day. Experts say that " frequent urination " is when you have to go to the bathroom more than eight (8) times in 24 hours. Wake up at night to urinate: OAB can wake a person from sleep to go to the bathroom more than once a night.

Can stress and anxiety cause OAB? ›

Stress, anxiety, and depression may actually contribute to OAB and urinary incontinence. In a study involving more than 16,000 women in Norway, having anxiety or depression symptoms at baseline was associated with a 1.5- to two-fold increase in the risk of developing urinary incontinence.

Can your mind control your bladder? ›

The brain and the bladder must communicate to make sure that we only urinate when and where it is appropriate. The process of urination is partly controlled by reflexes and is partly under conscious control (de Groat et al., 2015).

Can anxiety make your bladder overactive? ›

A lesser-known symptom of anxiety is also an overactive bladder . An overactive bladder is usually associated with urinary urgency and can sometimes lead to urinary incontinence as a by-product (though this is not always a given).

What relaxes the bladder? ›

Anticholinergic medicines help relax the muscles of the bladder. They include oxybutynin (Oxytrol, Ditropan), tolterodine (Detrol), darifenacin (Enablex), trospium (Sanctura), and solifenacin (VESIcare). Beta agonist drugs can also help relax the muscles of the bladder.

Is there a tablet for bladder control? ›

Mirabegron works by relaxing the muscles around your bladder. This means your bladder can hold more liquid and reduces your need to pee as often or as urgently. This medicine is only available on prescription. It comes as slow-release tablets (called "modified release" or "prolonged release").

What medication can I take to control my bladder? ›

Anticholinergics. These medications can calm an overactive bladder and may be helpful for urge incontinence. Examples include oxybutynin (Ditropan XL), tolterodine (Detrol), darifenacin (Enablex), fesoterodine (Toviaz), solifenacin (Vesicare) and trospium chloride.

Does vitamin D Help overactive bladder? ›

Conclusions: Vitamin D supplements and improved calcium intake may improve urinary and psychological symptoms and quality of life among patients with OAB syndrome. Assessment for vitamin D status in patients with OAB may be warranted.

What foods make overactive bladder worse? ›

Bladder irritants
  • Coffee, tea and carbonated drinks, even without caffeine.
  • Alcohol.
  • Certain acidic fruits — oranges, grapefruits, lemons and limes — and fruit juices.
  • Spicy foods.
  • Tomato-based products.
  • Carbonated drinks.
  • Chocolate.

What herb helps with overactive bladder? ›

Horsetail. Horsetail is an herb used to treat a variety of ailments. Among them are some symptoms of OAB including: urinary leaks (incontinence)

What is the cheapest medication for overactive bladder? ›

Prices for popular overactive bladder medications
  • Ditropan XL (oxybutynin ER) as low as. $22. ...
  • oxybutynin. as low as. $20. ...
  • Hyosyne (hyoscyamine) as low as. $17. ...
  • Levsin (hyoscyamine) as low as. $17. ...
  • Myrbetriq. as low as. $427. ...
  • tolterodine ER. as low as. $38. ...
  • Vesicare. as low as. $383. ...
  • trospium. as low as. $24.

What does a urologist do for overactive bladder? ›

Treatment for Overactive Bladder

Our urologists treat patients with OAB with combinations of behavioral therapy, medication, and in severe cases, a therapy called Interstim, to treat overactive bladder. Another option is the injection of Botox into the bladder to relax and paralyze the overactive muscle.

Are you born with OAB? ›

Some people have a genetic predisposition to OAB. Urinary incontinence sometimes runs in families. Additionally, men who develop OAB should have a prostate exam to determine whether or not the urinary tract is constricted.

Does holding Pee help overactive bladder? ›

Holding urine can overstretch the bladder and lead to voiding dysfunction, which is a lack of coordination between the bladder muscle and the urethra. This can result in an overactive bladder and urine leakage.

How do doctors tell if you have an overactive bladder? ›

Urinalysis. Taking a urine sample allows your doctor to check for conditions that can cause overactive bladder. A urinalysis looks for the presence of these substances in the urine: Bacteria or white blood cells, which could indicate a urinary tract infection or inflammation.

Is peeing every 2 hours normal? ›

It's considered normal to have to urinate about six to eight times in a 24-hour period. If you're going more often than that, it could simply mean that you may be drinking too much fluid or consuming too much caffeine, which is a diuretic and flushes liquids out of the body.

How can I stop my overactive bladder naturally? ›

Natural remedies
  1. Foods to avoid. Foods and drinks, which are known to cause or worsen the symptoms of OAB include: ...
  2. Manage fluid intake. Drinking enough water is essential for health. ...
  3. Scheduled urination. ...
  4. Delayed urination. ...
  5. Double-void technique. ...
  6. Kegel contractions. ...
  7. Quitting smoking. ...
  8. Discussing medications with a doctor.
24 Apr 2017

What are the four main symptoms of an overactive bladder? ›

Signs and Symptoms of Overactive Bladder

Difficulty holding in urine. Frequent urination (often eight times or more within 24 hours) Unintentional loss of urine with urgent need to urinate (urgency incontinence) Waking up more than once or twice at night to urinate (nocturia)

Does drinking water help with overactive bladder? ›

Because the bladder can only hold so much fluid volume, increasing water intake will increase the frequency of urination, and may make people with an overactive bladder more likely to leak. If you have overactive bladder (OAB), more fluid intake typically equals more trips to the bathroom.

What can calm the bladder? ›

6 Tricks to a Calm Bladder
  • Defeat Dehydration and Drink Water. It is common knowledge that drinks with a high amount of caffeine can irritate the bladder. ...
  • Try Chamomile and Peppermint Teas. ...
  • Choose Foods that Reduce Constipation. ...
  • Eat Foods Rich in Magnesium.
4 Dec 2018

What foods stop overactive bladder? ›

Bananas, apples, grapes, coconut and watermelon are good options for those with overactive bladder. Vegetables - Leafy greens, like kale, lettuce, cucumber, squash, potatoes, broccoli, carrots, celery and bell peppers. Whole grains, like oats, barley, farro, and quinoa (also a great protein).

What is the newest medication for overactive bladder? ›

GEMTESA (vibegron) for the Treatment of Overactive Bladder (OAB) GEMTESA® (vibegron) is a new oral medication indicated for the treatment of overactive bladder (OAB) with signs of urge urinary incontinence (UUI), urgency and urinary frequency in adults.

What is the best supplement for overactive bladder? ›

Magnesium. Magnesium is important for proper muscle and nerve function. Some doctors believe better magnesium levels can reduce bladder spasms, a common cause of incontinence.

What tea is good for overactive bladder? ›

Green tea (Camellia sinensis)

Research supports green tea as a preventative strategy for OAB.

What herb is good for overactive bladder? ›

Horsetail. Horsetail is an herb used to treat a variety of ailments. Among them are some symptoms of OAB including: urinary leaks (incontinence)

Is overactive bladder lifelong? ›

Conversely, about 40% to 70% of urinary incontinence is due to overactive bladder. Overactive bladder is not life-threatening, but most people with the condition have problems for years.
...
Overactive bladder
DurationOften years
CausesUnknown
Risk factorsObesity, caffeine, constipation
10 more rows

What does a urologist do for overactive bladder? ›

Treatment for Overactive Bladder

Our urologists treat patients with OAB with combinations of behavioral therapy, medication, and in severe cases, a therapy called Interstim, to treat overactive bladder. Another option is the injection of Botox into the bladder to relax and paralyze the overactive muscle.

Is an overactive bladder a disability? ›

Loss of bladder control is a serious disorder that may impact your ability to work. If you have bladder control problems, you may be eligible for Social Security Disability Insurance (SSDI) or Long Term Disability (LTD) benefits.

Videos

1. How to STOP BLADDER FREQUENCY | Overactive Bladder 101
(Michelle Kenway)
2. Causes and Treatments for Overactive Bladder Syndrome
(Williamson Medical Center)
3. Overactive Bladder Diet - Key Foods to AVOID with Urgency
(Michelle Kenway)
4. Treatment for Overactive Bladder & Urge Incontinence, Dr. Ja-Hong Kim | UCLAMDChat
(UCLA Health)
5. Overactive bladder syndrome: A Biopsychosocial approach - Carolyn Vandyken
(Continence Foundation of Australia)
6. Overactive Bladder Symptoms & Treatments
(McLaren Northern Michigan)
Top Articles
Latest Posts
Article information

Author: Manual Maggio

Last Updated: 12/19/2022

Views: 6148

Rating: 4.9 / 5 (49 voted)

Reviews: 80% of readers found this page helpful

Author information

Name: Manual Maggio

Birthday: 1998-01-20

Address: 359 Kelvin Stream, Lake Eldonview, MT 33517-1242

Phone: +577037762465

Job: Product Hospitality Supervisor

Hobby: Gardening, Web surfing, Video gaming, Amateur radio, Flag Football, Reading, Table tennis

Introduction: My name is Manual Maggio, I am a thankful, tender, adventurous, delightful, fantastic, proud, graceful person who loves writing and wants to share my knowledge and understanding with you.